Profile image
Story Views

Last Hour:
Last 24 Hours:

Premature Ejaculation Pipeline Review H2 2016: Stage of Development and Molecule Type Analysis

Monday, November 14, 2016 3:26
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Latest Premature Ejaculation Pipeline Review, H2 2016, provides in depth analysis on Cellular Tumor Antigen P53 (Tumor Suppressor P53 or Antigen NY-CO-13) targeted pipeline therapeutics.

Premature Ejaculation therapeutics industry report provides comprehensive information on the therapeutics under development for Premature Ejaculation, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Premature Ejaculation and features dormant and discontinued projects.

Browse more detail information about Premature Ejaculation market report at:


Premature ejaculation (PE) is also known as rapid ejaculation, is the most common type of sexual dysfunction in men. Ejaculation is controlled by the central nervous system. This happens when sexual stimulation and friction provide impulses that are delivered to the spinal cord and into the brain. The predisposing factors include erectile dysfunction, stress and certain medications that influence the action of chemical messengers in the brain (psychotropics) may contribute to premature ejaculation. Treatment includes topical anesthetic creams and antidepressants.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Key players in Premature Ejaculation – Pipeline Review, H2 2016:

  • Allergan Plc
  • Ixchelsis Limited
  • NeuroHealing Pharmaceuticals Inc.
  • Plethora Solutions Holdings Plc
  • SK Chemicals Co., Ltd.

Get a PDF Sample of Premature Ejaculation Market Research Report at:

Drug Profiles of Included in Premature Ejaculation Therapeutics Development Market Report

  • Modafinil
  • NCE-405
  • onabotulinumtoxin A


And other drug profiles

Have any query? ask our expert @

Key Topics Covered:
2.Premature Ejaculation Overview
3.Premature Ejaculation Therapeutics Development
4.Pipeline Products for Premature Ejaculation – Overview
5.Pipeline Products for Premature Ejaculation – Comparative Analysis
6.Premature Ejaculation – Therapeutics under Development by Companies
7.Premature Ejaculation – Therapeutics under Investigation by Universities/Institutes
8.Premature Ejaculation Products Glance
9.Late Stage Products
10.Clinical Stage Products
11.Early Stage Products
12.Premature Ejaculation – Products under Development by Companies
13.Premature Ejaculation – Products under Investigation by Universities/Institutes
14.Premature Ejaculation – Companies Involved in Therapeutics Development
15.Premature Ejaculation Drug Profiles
16.Premature Ejaculation Dormant Projects
17.Premature Ejaculation Discontinued Products
18.Premature Ejaculation Featured News & Press Releases
And Continue…

Get Discount on Premature Ejaculation Market Research Report at:

This research study help to:
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Premature Ejaculation
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Premature Ejaculation pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline


About Absolute Report:

Absolute Reports is an upscale platform to help key personnel in the business world in strategizing and taking visionary decisions based on facts and figures derived from in depth market research. We are one of the top report resellers in the market, dedicated towards bringing you an ingenious concoction of data parameters.


Mr. Ameya Pingaley

Absolute Reports

+1-408 520 9750

Email – [email protected]


Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Top Global


Top Alternative



Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.